Cargando…
Protocol for generating airway organoids from 2D air liquid interface-differentiated nasal epithelia for use in a functional CFTR assay
We present a protocol to generate organoids from air-liquid-interface (ALI)-differentiated nasal epithelia. We detail their application as cystic fibrosis (CF) disease model in the cystic fibrosis transmembrane conductance regulator (CFTR)-dependent forskolin-induced swelling (FIS) assay. We describ...
Autores principales: | Rodenburg, Lisa W., van der Windt, Isabelle S., Dreyer, Henriette H.M., Smits, Shannon M.A., den Hertog - Oosterhoff, Loes A., Aarts, Ellen M., Beekman, Jeffrey M., Amatngalim, Gimano D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511861/ https://www.ncbi.nlm.nih.gov/pubmed/37314920 http://dx.doi.org/10.1016/j.xpro.2023.102337 |
Ejemplares similares
-
Exploring intrinsic variability between cultured nasal and bronchial epithelia in cystic fibrosis
por: Rodenburg, Lisa W., et al.
Publicado: (2023) -
Drug Repurposing for Cystic Fibrosis: Identification of Drugs That Induce CFTR-Independent Fluid Secretion in Nasal Organoids
por: Rodenburg, Lisa W., et al.
Publicado: (2022) -
Measuring cystic fibrosis drug responses in organoids derived from 2D differentiated nasal epithelia
por: Amatngalim, Gimano D, et al.
Publicado: (2022) -
Dynamic regulation of airway surface liquid pH by TMEM16A and SLC26A4 in cystic fibrosis nasal epithelia with rare mutations
por: Delpiano, Livia, et al.
Publicado: (2023) -
Novel opportunities for CFTR-targeting drug development using organoids
por: Dekkers, Johanna F, et al.
Publicado: (2013)